ZI-Mannheim: Publikationen

Polymorphisms in the glutamate transporter gene SLC1A1 and obsessive compulsive symptoms induced by second generation antipsychotic agents
Frederike Schirmbeck, Vanessa Nieratschker, Josef Frank, Susanne Englisch, Franziska Rausch, Andreas Meyer-Lindenberg, Marcella Rietschel and Mathias Zink
Psychiatric Genetics 2012 (in press)

Treatment resistant schizophrenia: Evidence-based strategies
Susanne Englisch and Mathias Zink
Mens Sana Monographs 2012 (in press)

Reduced striatal activation during reward anticipation due to appetite-provoking cues in chronic schizophrenia: A fMRI study
Oliver Grimm, Sabine Vollstädt-Klein, Lena Krebs, Mathias Zink, Michael Smolka
Schizophrenia research 2011 (in press)

Gene expression of glutamate transporters SLC1A1, SLC1A3 and SLC1A6 in the cerebellar subregions of elderly schizophrenia patients and effects of antipsychotic treatment
Martina von Wilmsdorff, MD, Carolin Blaich, MD, Mathias Zink, MD, Jens Treutlein, PhD, Manfred Bauer, MD, Thomas Schulze, MD, Thomas Schneider-Axmann, Oliver Gruber, MD, Marcella Rietschel, MD, Andrea Schmitt, MD, Peter Falkai, MD
The World Journal of Biological Psychiatry 2011 (in press)

Combination and Augmentation Strategies in Treatment-resistant Schizophrenia.
Susanne Englisch and Mathias Zink
Drug Discovery Today: Therapeutic Strategies 2011 8(1-2): 17-23

Wenn Ängste zum Wahn werden
Andrea Esser, Franziska Rausch, Mathias Zink
Ärztliche Praxis Neurologie Psychiatrie 2011 (in press)

Clozapine-induced obsessive-compulsive symptoms in schizophrenia: A critical review
Frederike Schirmbeck and Mathias Zink
Current Neuropharmacology 2011 (in press)

Decreased reelin expression in the left prefrontal cortex (BA9) in chronic schizophrenia patients
Gregor Habl, Andrea Schmitt, Mathias Zink, Martina von Wilmsdorff, Peyman Yeganeh-Doost, Alexander Jatzko, Thomas Schneider-Axmann, Manfred Bauer, Peter Falkai
Neuropsychobiology 2011 (in press)

Aripiprazole improves olanzapine-associated obsessive compulsive symptoms in schizophrenia
Sandra Schönfelder, Frederike Schirmbeck, Robert Waltereit, Susanne Englisch, Mathias Zink
Clinical Neuropharmacology 2011; 34(6): 256 - 257

Practical Guidance for Prescribing Ziprasidone in Acute Manic or Mixed Episodes of Bipolar I disorder
Cañas F, Correll CU, Fagiolini A, Larmo I, Levy P, Papageorgiou G, Rossi A, Sturlason R, Zink M, Montes J-M
Expert Opinion in Pharmacotherapy (in press)

Perinatal exposure to alcohol disturbs spatial learning and glutamate transmission-related gene expression in the adult hippocampus
Mathias Zink, Thomas Ferbert, Stefanie Th. Frank, Patricia Seufert, Peter J. Gebicke-Haerter, and Rainer Spanagel
European Journal of Neuroscience 2011 (in press)

Mixed results for aripiprazole augmentation in non-responders to clozapine. Commentary on Muscatello et al. (2011)
Mathias Zink
The Brown University Psychopharmacology Update July 2011

Pregabalin-associated increase of clozapine serum levels
Susanne Englisch, Barbara Alm, Andreas Meyer-Lindenberg and Mathias Zink
Journal of Clinical Psychopharmacology 2011 (in press)

Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain
Nina Segnitz, Thomas Ferbert, Andrea Schmitt, Peter Gass, Peter J. Gebicke-Haerter, and Mathias Zink
Psychopharmacology (in press) (DOI: 10.1007/s00213-011-2262-z)

Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia
Schirmbeck F, Esslinger C, Rausch F, Englisch S, Meyer-Lindenberg A, and Zink M
Psychological Medicine 2011 (in press)

Individualizing antipsychotic treatment selection in schizophrenia: Characteristics of empirically derived patient subgroups.
Christoph U. Correll, F. Cañas; I. Larmo, P. Levy, J.M. Montes, A. Fagiolini , G. Papageorgiou, A. Rossi, R. Sturlason, M. Zink
European Psychiatry 26 (2011) 3 -16

Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe
G. Papageorgiou, F. Cañas; M. Zink, A. Rossi,
European Psychiatry 26 (2011) 17 - 28

Fluoxetine-treatment induces the expression of EAAT2 in rat brain
Zink M, Rapp S, Donev R, Gebicke-Haerter P J, and Thome J
Journal of Neural Transmission 2011. 118(6): 849 - 855

Polypharmazie bei schizophrenen Psychosen
Mathias Zink, Susanne Englisch, Andreas Meyer-Lindenberg
Der Nervenarzt 2011 (in press)

Switching Among Antipsychotics in Everyday Clinical Practice: Focus on Ziprasidone
Alessandro Rossi, MD; Fernando Cañas, MD; Andrea Fagiolini, MD; Ilkka Larmo, MD; Pedro Levy, MD; José Manuel Montes, MD; Georgios Papageorgiou, MD; Runa Sturlason, MD; Mathias Zink, MD; and Christoph U. Correll, MD
Postgraduate Medicine 2011. 123 (1) DOI: 10.3810/pgm.2011.01.2255

Zwangssyndrome bei Schizophrenie
Schirmbeck F and Zink M
Ärztliche Praxis Neurologie Psychiatrie 2011(1): 20 - 22

Buchkapitel:
Neurobiology of Alcohol Addiction
Rainer Spanagel, Mathias Zink, Wolfgang Sommer
In: Neuroscience in the 21. Century
Editor in Chief: Donald Pfaff
Springer Verlag (in press)

The hypoxic rat model for obstetric complications in schizophrenia
Andrea Schmitt, Peter Gebicke-Haerter, Ulrich Sommer, Markus Heck, Anja Lex, Mario Herrera-Marschitz, Mathias Zink, Markus Fendt, Peter Falkai
In: Animal Models of Schizophrenia. (in press)
Editor: Patricio O’Donnell
Humana press (Springer)